Diligence memo · auto-generated · as of July 2, 2026

PHARMANETUSA INC. Doing Business As Elithea Sciences

PHARMANETUSA INC. Doing Business As Elithea Sciences looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

PHARMANETUSA INC. Doing Business As Elithea Sciences operates in Other Health Care, based in Boca Raton.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

PHARMANETUSA INC. Doing Business As Elithea Sciences has raised $21M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $20M on —.

Valuation (modeled)modeled

Provath models PHARMANETUSA INC. Doing Business As Elithea Sciences at approximately $71M (range $47M–$87M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.23× the median modeled value of Series B Other Health Care companies (458 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

No dated round to assess.

The last round was 100.0× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 85% of Other Health Care peers (5377 compared).

Modeled value ranks above 72% of those peers.

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.